COM:FORMYCON
Formycon AG
- Stock
locale
Germanymarket
STOCKSindustry
Pharmaceuticalswebsite
www.formycon.comipo date
Jan 04, 2011
Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate t...Show More